Impaired mitochondrial function is a hallmark of metabolic dysfunction, and GLP-1s may help restore proper mitochondrial activity, further enhancing metabolic health
Your healthcare provider should review your treatment at least annually, considering whether continued GLP-1 therapy remains beneficial and whether dose adjustment might optimize outcomes
MaksimovaMYIvanovAVVirusEDNikiforovaKAOchtovaFRSuanovaETet alImpact of glutathione on acute ischemic stroke severity and outcome: possible role of aminothiols redox status
GLP-1 RAs showed trends toward improvements in endocrine and metabolic, cardiovascular, renal, and respiratory outcomes, cognitive function, with a potential reduction in fracture risk and all-cause mortality in certain populations
Serious but rare: pancreatitis, kidney injury, severe allergic reactions, possible thyroid tumors, severe hypoglycemia, mood changes, and vision problems